Study reveals age-specific differences in nasal cells' response to SARS-CoV-2
Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led...
View ArticleNew trials show promise for immune checkpoint blockers in early-stage lung...
A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).
View ArticleAging affects immune response and virus dynamics in COVID-19 patients, study...
A study examining 1031 hospitalized COVID-19 patients found that aging significantly impacts immune responses, viral dynamics, and the nasal microbiome, with older adults experiencing more severe...
View ArticleStudy reveals key protein's role in balancing immune response to viral...
Researchers have revealed the regulatory mechanism of a specific protein that plays a key role in balancing the immune response triggered by viral infections in mammal cells.
View ArticleStudy links air pollution to increased colorectal cancer risk through DNA...
Researchers reveal how air pollution increases colorectal cancer (CRC) risk through epigenetic changes, using a large-scale study and Mendelian randomization to demonstrate ambient pollution’s impact...
View ArticleRepurposed nasal antibiotic neomycin shows promise in preventing and treating...
Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against respiratory viruses like influenza A and SARS-CoV-2 by inducing...
View ArticleTherapeutic potential of human umbilical cord-derived mesenchymal stem cells...
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
View ArticleMIT study reveals circadian impact on drug metabolism in engineered livers
Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.
View ArticleGenetically modified mice reveal key players in immune defense against viruses
Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors.
View ArticleRevvity unveils a new era of automated tuberculosis testing
Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to...
View Article
